| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $504K | — |
| Cost of Revenue | $344K | — |
| Gross Profit | $160K | — |
| R&D Expense | $1.6M | +0.2% |
| SG&A Expense | $6.2M | +103.6% |
| Operating Income | -$7.6M | -65.1% |
| Pre-tax Income | -$14.2M | -115.9% |
| Income Tax | -$350K | -4.3% |
| Net Income | -$13.9M | -121.9% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | -44.3% |
| Inventory | $1.5M | +74.9% |
| Current Assets | $20.1M | -40.9% |
| Total Assets | $22.1M | -37.3% |
| Current Liabilities | $20.6M | +220.6% |
| Total Liabilities | $21.6M | -19.5% |
| Stockholders' Equity | $466K | -94.4% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | -8.4% |
| Capital Expenditures | $482K | +430.9% |
| Investing Cash Flow | -$956K | -14.4% |
| Financing Cash Flow | -$6.4M | -116.8% |
| Free Cash Flow | -$7.0M | -14.7% |